Skip to main content
Home
FULL MENU Close Menu
Home
Home

Alan P. Lyss, MD

News

New targeted treatments are major advances for HER2-positive breast cancer

Author:
Alan P. Lyss, MD
Publish date: May 21, 2021

Dr. Alan Lyss reviews data on HER2-targeted therapies in breast cancer.

  • Read More

Article

The power and promise of social media in oncology

Author:
Alan P. Lyss, MD
Publish date: May 3, 2021

Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.

  • Read More

Article

IMvigor130: A treasure trove of data for urothelial carcinoma

Author:
Alan P. Lyss, MD
Publish date: April 23, 2021

Dr. Alan Lyss reviews updated results with atezolizumab in locally advanced or metastatic urothelial carcinoma.

  • Read More

Article

Leveraging the microbiome to enhance cancer treatment

Author:
Alan P. Lyss, MD
Publish date: April 16, 2021

Dr. Alan Lyss reviews research suggesting that an antibiotic can improve the efficacy of radiotherapy.

  • Read More

Article

Steroid-refractory pneumonitis from ICIs: Experience at major centers

Author:
Alan P. Lyss, MD
Publish date: April 9, 2021

Dr. Alan Lyss explores two studies of patients with steroid-resistant or refractory pneumonitis resulting from...

  • Read More

Article

mCODE: Improving data sharing to enhance cancer care

Author:
Alan P. Lyss, MD
Publish date: March 12, 2021

Dr. Alan Lyss explores mCODE, a project designed to improve the sharing of data from cancer patients.

  • Read More

Article

Genetic testing for breast and ovarian cancer: What has changed and what still needs to change?

Author:
Alan P. Lyss, MD
Publish date: March 5, 2021

Dr. Alan Lyss reviews a study that revealed trends in genetic testing over time.

  • Read More

Opinion

Enfortumab vedotin offers hope to poor-prognosis patients with advanced urothelial cancer

Author:
Alan P. Lyss, MD
Publish date: February 26, 2021

EV is an antibody-drug conjugate directed against nectin-4, an immunoglobulin-like cell adhesion molecule that...

  • Read More

Article

How has the pandemic affected rural and urban cancer patients?

Author:
Alan P. Lyss, MD
Publish date: February 18, 2021

A survey suggests the pandemic has impacted rural and urban cancer patients somewhat differently.

  • Read More

Article

X-ray vision: Using AI to maximize the value of radiographic images

Author:
Alan P. Lyss, MD
Publish date: February 16, 2021

Dr. Alan Lyss reviews studies using artificial intelligence to predict lung cancer risk and outcomes.

  • Read More

Article

ctDNA outperforms CEA in colorectal cancer

Author:
Alan P. Lyss, MD
Publish date: January 26, 2021

Circulating tumor DNA testing bested carcinoembryonic antigen testing in a study of patients with colorectal...

  • Read More

Article

RSClin: A new tool for ‘TAILOR-ing’ treatment in early breast cancer

Author:
Alan P. Lyss, MD
Publish date: January 14, 2021

Dr. Alan P. Lyss describes RSClin, a tool for estimating the risk of distant relapse in breast cancer. ...

  • Read More

Article

DART trial hits the target in angiosarcoma

Author:
Alan P. Lyss, MD
Publish date: December 24, 2020

Dr. Alan Lyss reviews results of the DART trial and highlights the value of clinical trials for rare cancers....

  • Read More

Article

How should we evaluate the benefit of immunotherapy combinations?

Author:
Alan P. Lyss, MD
Publish date: December 10, 2020

Dr. Alan Lyss examines how new endpoints, novel study design, and other methods might better quantify the...

  • Read More

Article

Using telehealth to deliver palliative care to cancer patients

Author:
Alan P. Lyss, MD
Publish date: November 17, 2020

Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close